| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |